Regulated Information Leuven, BELGIUM, Boston, MA, US – March 31, 2023 – 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company.
Investegate announcements from Oxurion NV, Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas Special Opportunities LL